We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for deve... Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. Show more
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.64 | -0.544217687075 | 117.6 | 119.08 | 114.37 | 630019 | 116.84384013 | CS |
4 | -12.87 | -9.9129631056 | 129.83 | 131.16 | 114.37 | 623616 | 123.63027242 | CS |
12 | -3.54 | -2.9377593361 | 120.5 | 143 | 114.37 | 810472 | 126.2875762 | CS |
26 | 5.96 | 5.36936936937 | 111 | 143 | 55.25 | 1329891 | 99.97339322 | CS |
52 | -10.21 | -8.02862310293 | 127.17 | 159.89 | 55.25 | 1257591 | 110.24661647 | CS |
156 | 45.69 | 64.1083204714 | 71.27 | 159.89 | 55.25 | 1107461 | 101.98385283 | CS |
260 | 2.98 | 2.61449377084 | 113.98 | 181.83 | 55.25 | 1145889 | 106.7166395 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions